Andaleb Kholmukhamedov/LinkedIn
Oct 4, 2025, 12:38
Andaleb Kholmukhamedov: Anticoagulation Management: Current Landscape And Future Trends
Andaleb Kholmukhamedov, Head of Hemostasis Assay Development at Werfen North America, posted on LinkedIn:
”Latest publication in the MDPI Journal of Clinical Medicine’s Special Issue on Advances in Thrombosis and Haemostasis
Our paper provides a comprehensive review of the current and future landscape of Anticoagulation Therapy – a critical field balancing life-saving clot prevention with bleeding risk.”
Read the full article here.
Title: Anticoagulation Management: Current Landscape and Future Trends
Authors: Andaleb Kholmukhamedov, David Subbotin, Anna Gorin, Ruslan Ilyassov
Stay updated with Hemostasis Today.
Andaleb Kholmukhamedov
Anna Gorin
Anticoagulation
Anticoagulation Management
Anticoagulation Therapy
Bleeding Risk
Blood Clot
David Subbotin
Health
Hematology
Hemostais
Hemostais Today
MDPI Journal
Medicine
Ruslan Ilyassov
San Diego State University
Scripps Memorial Hospital
thrombosis
University of California Los Angeles
Versiti Blood Research Institute
Werfen North America
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia